Search
for
Sort by
Research 391–420 of 1000+
- Novel potential therapeutic targets of alopecia areata
- Treatment of severe alopecia areata with oral tofacitinib: A case series
- POS0080 TOFACITINIB TREATMENT IN CHILDREN WITH RHEUMATIC DISEASES: SINGLE-CENTER EXPERIENCE
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- A Discrete Choice Experiment of Clinician Preferences Among Attributes of Approved Janus Kinase Inhibitors for Alopecia Areata
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- ПОДРЫВАЮЩИЙ ФОЛЛИКУЛИТ ГОФФМАНА. ПРИНЦИПЫ ДИАГНОСТИКИ И ЛЕЧЕНИЯ: ОБЗОР ЛИТЕРАТУРЫ
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Janus Kinase (JAK) Inhibitors in Dermatology: An Update and Critical Review
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- Follicular Vitiligo: A Rare and Under Recognized Variant
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Is female-pattern hair loss an autoimmune-like disorder? Unveiling the “silent” inflammation
- Real-world evidence in alopecia areata treatment: A narrative review
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- 008 Stratifying alopecia areata systemic treatments: Tailored approaches to disease severity
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Alopecia Universalis with Frequently Relapsing Nephrotic Syndrome of Infantile Onset: A Rare Presentation
- A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- 151 Efficacy and adverse effects of oral Janus kinase inhibitor (JAKi) use in patients with lichen planopilaris: a retrospective case series and systematic review
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Review of efficacy of baricitinib in the treatment of alopecia areata
- New Treatment Options for Alopecia Areata
- USE OF TOFACITINIB IN DIFFICULT TO TREAT CLINICALLY AMYOPATHIC DERMATOMYOSITIS
- A retrospective review of paediatric alopecia areata cases seen in a tertiary institution in Singapore